Michael Mingueneau

Yaklaşan katılımlar

• 4th Cell Therapy for Autoimmune Disease Summit 2026

  1–3 Dec 2026Philadelphia, United States of America

  • KonuşmacıIn Vivo CD19 CAR-T Cell Engineering with Endless RNA (eRNA) & Pan-T Cell-Targeted Lipid Nanoparticles Drives Deep B-Cell Depletion & Immune Reset with Superior Dose Potency

Geçmiş katılımlar

• 11th CAR-TCR Summit 2026

  15–17 Sept 2026Boston, United States of America

  • KonuşmacıDisrupting the Autoimmune Disease Treatment Paradigm - Transient, Potent, & Scalable eRNA-based In Vivo CD19 CAR-T Therapy

Şu etkinlikteki diğer konuşmacılar: 4th Cell Therapy for Autoimmune Disease Summit 2026

• Fred Aslan

  President & Chief Executive Officer, Artiva Biotherapeutics, Inc

• Rena Baek

  Executive Director, Preclinical Development, Moderna

• Daniel Shelly

  Chief Business Development Officer, PolTREG

• Edward Zhang

  Co-Founder & Chief Executive Officer, Overland Therapeutics

• Mark Bach

  Chief Medical Officer, GentiBio

• Nathalie Belmonte

  Chief Science & Technical Officer, Quell Therapeutics

Etkinlik sayfasında 22 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: 11th CAR-TCR Summit 2026

• James Adams

  Chief Technical Officer, Tr1x therapeutics

• Stephan Krause

  Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

• Luke Pase

  Chief Technology Officer, Anocca AB

• Daniel Shelly

  Chief Business Development Officer, PolTREG

• Hong Xin

  Senior Director, Oncology Scientific Innovation, Johnson & Johnson

Etkinlik sayfasında 83 konuşmacının tümünü gör